ArticleObesity surgery2026
Beyond Weight Loss: A Decade of Insights into Quality of Life and Well-Being After Laparoscopic Sleeve Gastrectomy.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate 10-year outcomes after laparoscopic sleeve gastrectomy (LSG), focusing on weight loss, quality of life, patient satisfaction, physical activity, and psychosocial factors.
methodsA prospective cohort of 300 patients who underwent LSG between January 2013 and July 2014 was evaluated. Inclusion criteria were first-time metabolic bariatric surgery, age ≥18 years, and absence of perioperative complications. Long-term follow-up was achieved for 193 patients (64.3% retention).
resultsAt baseline, mean BMI was 42.54 ± 5.10 kg/m² and mean age 42.86 ± 10.65 years. Substantial weight loss occurred, with BMI decreasing to 29.15 kg/m² at one year (p < .001). Weight regain began after three years, reaching a mean BMI of 31.89 kg/m² at 10 years, while 51.5% maintained ≥25% excess weight loss. Overall, quality of life improved in 86.1% of patients, with over half reporting excellent outcomes. The greatest improvements occurred in the self-esteem, physical activity, and social engagement domains of the MA-II, with smaller gains in sexual satisfaction and eating behavior. A significant decline in global quality of life (QOL) was observed over time (p < .001). Postoperatively, 59.3% participated in structured physical activity programs, while 40.7% remained sedentary. Psychosocial benefits included enhanced interpersonal relationships (35.6%) and greater social participation, although a minority reported marital strain (8.3%) or reduced overall satisfaction.
conclusionsLSG provides durable weight loss and significant improvements in quality of life across multiple MA-II domains, accompanied by high patient satisfaction (85.6%) and healthier lifestyle behaviors. Nonetheless, partial weight regains, sedentary habits, and variable psychosocial outcomes persist.
Indexed as
Identifiers
41806229What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.